Collaboration - September 27, 2022
Our Nordic Life Science Stars 2022!
These five Nordic life science companies are at different stages of development, with different focus areas, from different Nordic countries, and they represent the different strongholds that the region possesses. Sweden – Abera Bioscience Abera Bioscience has found the right recipe for giving its versatile vaccine platform the best possible conditions to succeed. “Our […]
Agreement - September 26, 2022
TILT Biotherapeutics signs new agreement with MSD
The Finnish company has signed a second clinical trial collaboration and supply agreement with MSD for a new clinical trial evaluating TILT-123, its oncolytic adenovirus armed with two human cytokines, in combination with Keytruda, MSD’s anti-PD-1 therapy. This Phase I, open label, dose escalation trial will include 12 to 24 patients with immune checkpoint inhibitor […]
Collaboration - September 21, 2022
RWE on the agenda at US-Swedish event
During a meeting at the US ambassador’s residence in Sweden on September 20th, collaboration on data driven life sciences and Real World Evidence’s (RWE’s) impact on Swedish life sciences was discussed. The meeting was arranged by MSD, SwedenBIO, Karolinska Institutet and the American Chamber of Commerce. “The event was important in order to showcase concrete […]
Collaboration - September 15, 2022
Lundbeck joins Real World Data consortium
The company has become a partner of EHDEN, a private-public partnership that is building a large-scale, federated network of data sources standardized to a common data model. Lundbeck now joins the 11 public partners, and 12 industry partners, adding our expertise, resources, and support in creating an ecosystem for working with real world data across […]
Collaboration - September 13, 2022
Our latest issue of NLS Magazine is out!
In this 108-page issue we have chosen to take a closer look at five Nordic innovation districts, at different development stages and with different challenges and life science offerings, but with the same goal of facilitating knowledge transfer and spurring innovation and life science growth in our region and beyond. In addition, we present our […]
Collaboration - September 13, 2022
Novo Nordisk and Microsoft enter collaboration
The two companies have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence with Novo Nordisk’s drug discovery, development and data science capabilities. Through the partnership, Microsoft is providing AI technology, foundational science models and expertise and is working alongside Novo Nordisk’s data scientists and domain experts from early research […]